SEC 13F Intelligence

Hhlr Advisors, Ltd. / LEGN

Hhlr Advisors, Ltd.’s Legend Biotech Corp Position

Does Hhlr Advisors, Ltd. own Legend Biotech Corp (LEGN)? Yes — 5.98M shares worth $108M (+6.47% of its 13F portfolio) as of Q1 2026.

Position Value
$108M
Q1 2026
Shares
5.98M
% of Portfolio
+6.47%
Quarters Held
24
currently held

Position History LEGN

Reported value by quarter
Q2 ’20: $28MQ2 ’20Q3 ’20: $20MQ4 ’20: $18MQ1 ’21: $19MQ1 ’21Q2 ’21: $27MQ3 ’21: $559MQ4 ’21: $550MQ4 ’21Q1 ’22: $252MQ2 ’22: $244MQ3 ’22: $210MQ3 ’22Q4 ’22: $256MQ1 ’23: $247MQ2 ’23: $444MQ2 ’23Q3 ’23: $432MQ4 ’23: $360MQ1 ’24: $336MQ1 ’24Q2 ’24: $294MQ3 ’24: $323MQ4 ’24: $195MQ4 ’24Q1 ’25: $203MQ2 ’25: $212MQ3 ’25: $195MQ3 ’25Q4 ’25: $130MQ1 ’26: $108Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.98M$108M+6.47%
Q4 20255.98M$130M+4.19%
Q3 20255.98M$195M+4.77%
Q2 20255.98M$212M+6.84%
Q1 20255.98M$203M+5.74%
Q4 20245.98M$195M+6.74%
Q3 20246.64M$323M+7.10%
Q2 20246.64M$294M+7.25%
Q1 20245.98M$336M+7.29%
Q4 20235.98M$360M+7.26%
Q3 20236.44M$432M+9.65%
Q2 20236.44M$444M+9.46%
Q1 20235.13M$247M+4.39%
Q4 20225.14M$256M+5.41%
Q3 20225.14M$210M+5.51%
Q2 20224.44M$244M+5.23%
Q1 20226.94M$252M+5.26%
Q4 202111.80M$550M+8.50%
Q3 202111.05M$559M+7.31%
Q2 2021650.0K$27M+0.27%
Q1 2021650.0K$19M+0.19%
Q4 2020650.0K$18M+0.15%
Q3 2020650.0K$20M+0.15%
Q2 2020650.0K$28M+0.25%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hhlr Advisors, Ltd.’s full portfolio or all institutional holders of LEGN.